Jose M Miro

Prof. Jose M Miro

Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain
+2
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2023 in European Heart Journal
Verified
Journal Article
Closed access
VDVictoria Delgado
Victoria Delgado
Nina Ajmone MarsanNina Ajmone Marsan
Nina Ajmone Marsan
SWSuzanne de Waha
Suzanne de Waha
Nikolaos BonarosNikolaos Bonaros
Nikolaos Bonaros
MBMargarita Brida
Margarita Brida
KZKatja Zeppenfeld
Katja Zeppenfeld

1 May 2020 in The Lancet HIV
Verified
Journal Article
Closed access
JBJose L Blanco
Jose L Blanco
JAJuan Ambrosioni
Juan Ambrosioni
FGFelipe García
Felipe García
EMEsteban Martínez
Esteban Martínez
ASAlex Soriano
Alex Soriano
Jose M MiroJose M Miro
Jose M Miro

15 August 2005 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
Jose M MiroJose M Miro
Jose M Miro
IAIgnasi Anguera
Ignasi Anguera
CCChristopher H. Cabell
Christopher H. Cabell
ACAnita Y. Chen
Anita Y. Chen
JSJudith A. Stafford
Judith A. Stafford
IGInternational Collaboration on Endocarditis Merged Database Study Group
International Collaboration on Endocarditis Merged Database Study Group
Background. Staphylococcus aureus native valve infective endocarditis (SA-NVIE) is not completely understood. The objective of this investigation was

12 April 2017 in Current Infectious Disease Reports
Verified
Journal Article
Closed access
PDF file
TIthe Hospital Clinic Infective Endocarditis Investigators
the Hospital Clinic Infective Endocarditis Investigators
JAJ Ambrosioni
J Ambrosioni
MHMarta Hernández-Meneses
Marta Hernández-Meneses
ATAdrián Téllez
Adrián Téllez
JPJ Pericàs
J Pericàs
Jose M MiroJose M Miro
Jose M Miro

30 November 2004 in European Heart Journal
Verified
Journal Article
Open access
PDF file
IAIgnasi Anguera
Ignasi Anguera
Jose M MiroJose M Miro
Jose M Miro
IVIsidre Vilacosta
Isidre Vilacosta
BABenito Almirante
Benito Almirante
MAManuel Anguita
Manuel Anguita
AGAorto-cavitary Fistula in Endocarditis Working Group
Aorto-cavitary Fistula in Endocarditis Working Group
Aims To investigate the clinical features, echocardiographic characteristics, management, and prognostic factors of mortality of aorto-cavitary fistulization (ACF) in infective endocarditis (IE). Extension of infection in aortic valve IE beyond valvular structures may result in peri-annular complications with resulting necrosis and rupture, and subsequent development of ACF. Aorto-cavitary communications create intra-cardiac shunts, which may result in further clinical deterioration and haemodynamic instability. Methods and results In a retrospective multi-centre study over 4681 episodes of IE, a total of 76 patients with ACF [1.6%, confidence interval (CI) 95%: 1.2–2.0%] diagnosed by echocardiography or during surgery were identified. Fistulae were found in 1.8% of cases of native valve IE and in 3.5% of cases of prosthetic valve IE from the general population and in 0.4% of drug abusers. PVE was present in 31 (41%) cases of ACF. Transthoracic and transoesophageal echocardiography detected the fistulous tracts in 53 and 97% of cases, respectively. Peri-annular abscesses were detected in 78% of cases, fistulae originated in similar rates from the three sinuses of Valsalva, and the four cardiac chambers were equally involved in the fistulous tracts. Heart failure (HF) developed in 62% of cases and surgery was performed in 66 (87% CI 95% 77–93%) patients with a mortality of 41% (95% CI 30–53%) in the overall population. Multivariate analysis identified HF (OR 3.4, CI 95% 1.0–11.5), prosthetic IE (OR 4.6, CI 95% 1.4–15.4) and urgent or emergency surgical treatment (OR 4.3, CI 95% 1.3–16.6) as variables significantly associated with an increased risk of death. Major complications during follow-up (death, re-operation, or re-admission for HF) among the five operative survivors with residual fistulae occurred in 20 and 100% of patients at 1 and 2 years, respectively. Conclusion Aorto-cavitary fistulous tract formation is an uncommon but extremely serious complication of IE. In-hospital mortality was exceptionally high despite aggressive management with surgical intervention in the majority of patients. Prosthetic IE, urgent surgery, and the development of HF identify the subgroup of patients with IE and ACF that have significantly increased risk of in-hospital death.

1 May 2021 in The Lancet HIV
Verified
Journal Article
Closed access
JAJuan Ambrosioni
Juan Ambrosioni
JBJosé Luis Blanco
José Luis Blanco
JRJuliana M Reyes-Urueña
Juliana M Reyes-Urueña
MDMary-Ann Davies
Mary-Ann Davies
OSOmar Sued
Omar Sued
JMJose Muñoz
Jose Muñoz